How microbes change the cell's internal scaffold (actin)
Microbial mobilization of the actin cytoskeleton
Researchers are learning how harmless microbes alter the cell's actin framework, which could help people with heart disease, inflammation, or cancer in the long run.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11311926 on NIH RePORTER |
What this research studies
This lab uses harmless microbes as tools to reveal how the actin cytoskeleton is built and controlled inside cells and the nucleus. By watching how microbes mimic or hijack actin-regulating molecules, scientists use advanced imaging, biochemistry, and cell experiments to map the molecular steps that drive cell shape, movement, and fusion. Understanding these mechanisms can explain how actin problems contribute to inflammation, cardiovascular disease, and cancer spread. The work is done in controlled laboratory cell systems rather than as a clinical trial.
Who could benefit from this research
Good fit: People with cardiovascular disease, chronic inflammatory conditions, or cancers who want to follow research on the cellular causes of their diseases would be most interested in these findings.
Not a fit: Patients seeking immediate new treatments or participating in a clinical trial would likely not benefit directly because this is basic laboratory research rather than a patient treatment study.
Why it matters
Potential benefit: If successful, this work could identify new molecular targets that lead to better diagnostics or treatments for conditions linked to actin dysfunction like heart disease and cancer.
How similar studies have performed: Previous studies using microbes to probe cell biology have led to important discoveries about actin and other cellular systems, though the specific mechanisms targeted here remain an active area of research.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Welch, Matthew D — University of California Berkeley
- Study coordinator: Welch, Matthew D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.